I AM #HER

About HER2+ Breast Cancer

HER2+ breast cancer is a breast cancer that tests positive for a protein called Human Epidermal growth factor Receptor 2-positive (HER2+) , which promotes the growth of cancer cells.1

A plus sign means the cancer has the protein amplified, mutated or abnormal protein and its receptors.

HER2 nucleus cell Group1 g1 Group1 g2 Group1 g3 cell membrane

NORMAL CELL

Normal amount of HER2

HER2 nucleus cell1 Group1 g0 Group1 g1 Group1 g2 Group1 g3 Group1 g4 Group1 g5 Group1 g6 Group1 g7 Group1 g8 Group1 g9 Group1 g10 Group1 g11 Group1 g12 Group1 g13 Group1 g14 Group1 g15 Group1 g16 Group1 g17 cell membrane

CANCER CELL

Too much HER2

 

1 out of every 5

breast cancers have a gene mutation that makes an excess of the HER2 protein2,3

your doctor prescribed

Your doctor has prescribed OGIVRI the first FDA-approved biosimilar to HERCEPTIN® (trastuzumab)-for the treatment of your HER2+ breast cancer. OGIVRI is proven to be as safe and effective as HERCEPTIN. OGIVRI is an important part of the fuller collaboration between you, your doctor, and your extended care team.